"The winners in life are differentiated from the losers in life because the winners never fall," Albert Bourla says. "The ...

Pfizer's CEO thinks his company will make big waves in the weight loss market. Eli Lilly does have a strong hold on the industry and won't let go anytime soon. Even so, Lilly could carve out a niche ...

Pfizer Inc. is doubling down on the booming weight-loss drug race, with CEO Albert Bourla declaring the company will be a "formidable competitor" after securing a $10 billion deal to acquire ...

Ian Read talks with Here & Now's Jeremy Hobson about how one of the world's biggest pharmaceutical companies is adjusting to the new administration. Pfizer CEO On Trump, Drug Prices And The FDA ...

Find insight on GSK’s acquisition of RAPT Therapeutics, Novartis and more in the latest Market Talks covering Health Care.

NEW YORK, Oct 14 (Reuters) - Pfizer Chief Executive Albert Bourla said on Tuesday that the U.S. pharmaceutical industry needs to collaborate with China’s, where speedy processes have vaulted it to 30% ...

Pfizer’s battle with Novo Nordisk over control of obesity drug developer Metsera is getting nasty. After Pfizer apparently sealed a $4.9 billion purchase of Metsera in September, Novo Nordisk swooped ...

Robert F. Kennedy’s position on vaccines is profoundly "anti-science" and making progress would require a new health secretary, Pfizer Chief Executive Albert Bourla said Wednesday. “I have very ...